D. Weingand et al. / Tetrahedron 71 (2015) 1261e1268
1267
2.1 Hz, 1H, ]CHaHb), 5.13 (d, 3J 2.0 Hz, 1H, ]CHaHb); 13C NMR
saturated aqueous NH4Cl solution (1 mL) was added and most of
the MeOH was removed in vacuo. The remnant was dissolved in
CH2Cl2/H2O (1:1, 10 mL) and the aqueous layer was extracted with
CH2Cl2 (2ꢀ3 mL). The combined organic layers were dried
(Na2SO4), concentrated, and purified by columns chromatography
(silica gel, CH2Cl2/acetone, 10:1/5:1) to yield adduct 32eq (25 mg,
0.100 mmol, 19%) as a colorless solid together with MeOH adduct
33eq (10 mg, 0.045 mmol, 3%) and starting material 23 (3 mg,
0.016 mmol, 3%). Compound 32eq: Rf¼0.77 (CH2Cl2/acetone, 5:1); IR
(100 MHz, CDCl3)
d 27.3 (s), 31.8 (q), 33.9 (t), 47.9 (d), 72.8 (d),
104.1 (d), 160.3 (q); m/z (FAB) 189 (MHþ); HRMS (FAB): MHþ,
found 189.0946. C9H17O2S requires 189.0944.
5.14. (2S,3S,5S)- and (2S,3R,5S)-(5-tert-Butyl-3-oxido-1,3-
oxathian-2-yl)methyl 4-methylbenzenesulfonate (22 and 26)
(ATR): (cmꢂ1)¼2960 (m), 2870 (w), 1469 (w), 1368 (m), 1107 (m)
~
n
Alcohols 20 and 24 (1:1, 780 mg, 3.79 mmol) were reacted
according to the procedure given for tosylate 12 to yield a mixture
of tosylates 22 und 26 (1.05 g, 2.92 mmol, 98%) as a viscous oil,
which solidified after a while. Compound 22: Rf¼0.47 (CH2Cl2/ace-
~
1036 (s), 978 (m); 1H NMR (400 MHz, CDCl3)
d
0.94 (s, 9H, tBu), 1.25
(t, 3J 7.4 Hz, 3H, CH2CH3), 1.83 (dddd, 3J 2.4, 3.9, 11.2, 13.1 Hz, 1H, 5-
H), 2.53 (dd, 2J 11.8 Hz, 3J 12.8 Hz, 1H, 6-Hax), 2.65 (q, 3J 7.4 Hz, 2H,
CH2CH3), 2.95 (dd, 3J 8.6 Hz, 2J 14.3 Hz, 1H, CHaHbSEt), 3.24 (dd, 3J
2.2 Hz, 2J 14.3 Hz,1H, CHaHbSEt), 3.44 (dd, 3J 11.4,11.4 Hz,1H, 4-Hax),
3.62 (ddd, 4J 2.3 Hz, 3J 2.3 Hz, 2J 11.7 Hz, 1H, 6-Heq), 4.09 (dd, 3J 2.2,
8.6 Hz, 1H, 2-H), 4.18 (ddd, 4J 2.2 Hz, 3J 3.9 Hz, 2J 11.5 Hz, 1H, 4-Heq);
tone, 5:1); IR (ATR):
n
(cmꢂ1)¼3226 (w), 2957 (w), 2872 (w), 1365
(m), 1180 (m), 1032 (s), 970 (m), 551 (m); 1H NMR (400 MHz, CDCl3)
d
0.87 (s, 9H, tBu), 1.72 (m, 1H, 5-H), 2.38 (s, 3H, ArCH3), 2.47 (dd, J
11.8, 12.6 Hz, 1H, 4-Hax or 6-Hax), 3.33 (t, 3J 11.5 Hz, 1H, 2-H), 3.58
(m, 1H, 6-Hax or 4-Hax), 4.08 (m, 2H, 10-H), 4.36 (ddd, 4J 0.7 Hz, 3J
5.9 Hz, 2J 11.4 Hz, 1H, 4-Heq or 6-Heq), 4.45 (ddd, J 1.1, 2.1 Hz, 2J
11.6 Hz, 1H, 6-Heq or 4-Heq), 7.29 (d, 3J 8.1 Hz, 2H, Ar), 7.74 (d, 3J
13C NMR (100 MHz, CDCl3)
d 14.6 (s), 27.3 (d), 27.4 (s), 31.7 (d), 32.1
(q), 44.8 (t), 52.5 (d), 71.7 (d), 98.2 (t); m/z (FAB) 251 (MHþ); HRMS
(FAB): MHþ, found 251.1133. C11H23O2S2 requires 251.1134. Com-
8.2 Hz, 2H, Ar); 13C NMR (100 MHz, CDCl3)
d
21.6 (s), 27.4 (s), 32.1
n
pound 33eq: Rf¼0.57 (CH2Cl2/acetone, 5:1); IR (ATR): (cmꢂ1)¼
~
2958 (w), 2874 (w), 1469 (w), 1093 (s), 1036 (s); 1H NMR (400 MHz,
(q), 44.5 (t), 53.0 (d), 66.5 (d), 71.5 (d), 94.9 (t), 128.1 (t), 129.9 (t),
132.4 (q), 145.2 (q); m/z (FAB) 361 (MHþ); HRMS (FAB): MHþ, found
361.1136. C16H25O5S2 requires 361.1138. Compound 26: Rf¼0.69
~
CDCl3)
d
0.94 (s, 9H, tBu), 1.84 (dddd, 3J 2.3, 3.8, 11.1, 12.2 Hz, 1H, 5-
H), 2.53 (dd, 3J 11.9 Hz, 2J 12.7 Hz, 1H, 6-Hax), 3.44 (dd, 3J 11.3 Hz, 2J
11.3 Hz, 1H, 4-Hax), 3.45 (s, 3H, OCH3), 3.65 (ddd, 4J 2.2 Hz, 3J 2.2 Hz,
2J 11.6 Hz, 1H, 6-Heq), 3.87 (dd, 3J 2.3 Hz, 2J 11.2 Hz, 1H, CHaHbOCH3),
3.92 (dd, J 4.4 Hz, 2J 11.2 Hz, 1H, CHaHbOCH3), 4.07 (dd, 3J 2.2, 4.4 Hz,
1H, 2-H), 4.19 (ddd, 4J 2.2 Hz, 3J 3.9 Hz, 2J 11.5 Hz, 1H, 4-Heq); 13C
(CH2Cl2/acetone, 5:1); IR (ATR):
n
(cmꢂ1)¼3326 (m), 2959 (m), 1472
(w), 1367 (w), 1075 (s), 1010 (s), 971 (s), 848 (m), 582 (m); 1H NMR
(400 MHz, CDCl3)
d J
0.91 (s, 9H, tBu), 2.32 (m, 1H, 5-H), 2.45 (dd, 3
12.5 Hz, 2J 13.9 Hz, 1H, 6-Hax), 2.44 (s, 3H, ArCH3), 3.28 (ddd, 3J
2.5 Hz, 4J 2.5 Hz, 2J 13.8 Hz, 1H, 6-Heq), 3.50 (dd, 3J 11.4 Hz, 2J 11.4 Hz,
1H, 4-Hax), 4.20 (dd, 3J 6.6 Hz, 2J 11.0 Hz,1H, CHaHbOTs), 4.26 (ddd, 4J
2.7 Hz, 3J 3.6 Hz, 2J 11.8 Hz, 1H, 4-Heq), 4.28 (dd, 3J 6.2 Hz, 2J 11.0 Hz,
1H, CHaHbOTs), 4.40 (dd, 3J 6.4 Hz, 1H, 2-H); 13C NMR (100 MHz,
NMR (100 MHz, CDCl3) d 27.4 (s), 32.1 (q), 44.7 (t), 52.6 (d), 59.7 (s),
69.1 (d), 71.7 (d), 96.7 (t); m/z (FAB) 220 (Mþ); HRMS (EI): Mþ,
found 220.1126. C10H22O3S requires 220.1128.
CDCl3) d 21.7 (s), 27.2 (s), 31.4 (q), 32.2 (t), 46.2 (d), 66.3 (d), 71.4 (d),
5.17. (2S,3R,5S)-5-tert-Butyl-2-(piperidin-1-ylmethyl)-1,3-
87.9 (t), 128.1 (t), 130.0 (t), 132.0 (q), 135.4 (q).
oxathiane 3-oxide (30eq)
5.15. (2S,3R,5S)-5-tert-Butyl-2-(ethylthiomethyl)-1,3-
Piperidine (195 mL, 1.98 mmol) and DBU (1 drop) were added to
oxathiane 3-oxide (29eq)
a solution of vinyl sulfoxide 25 (93.0 mg, 0.49 mmol) in MeOH
(5 mL). The solution was heated for 5 d at 60 ꢁC and cooled to rt.
H2O (5 mL) and CH2Cl2 (20 mL) were added, the aqueous layer was
extracted with CH2Cl2 (2ꢀ2 mL), the combined organic layers were
dried (Na2SO4), concentrated, and purified by column chromatog-
raphy (silica gel, CH2Cl2/acetone, 2:1) to yield adduct 30eq (112 mg,
0.410 mmol, 83%) as a colorless solid. Rf¼0.16 (CH2Cl2/acetone, 2:1);
~
NaH (44.8 mg, 1.87 mmol) was added to a solution of vinyl
sulfoxide 25 (87.8 mg, 0.47 mmol) and ethanethiol (172
mL,
2.34 mmol) in MeOH (5 mL). After stirring for 24 h at rt saturated
aqueous NH4Cl solution (1 mL) was added and most of the MeOH
was removed in vacuo. The remnant was dissolved in CH2Cl2/H2O
(1:1, 10 mL) and the aqueous layer was extracted with CH2Cl2
(2ꢀ3 mL). The combined organic layers were dried (Na2SO4), con-
centrated, and purified by columns chromatography (silica gel,
CH2Cl2/acetone, 5:1) to yield adduct 29eq (101 mg, 0.403 mmol,
86%) as a colorless solid. Rf¼0.24 (cyclohexane/EtOAc, 1:1); IR
~
IR (ATR):
n
(cmꢂ1)¼3505 (w), 2936 (m), 2799 (w), 1467 (w), 1304
(w), 1100 (s), 1023 (s), 781 (m), 616 (m), 460 (m); 1H NMR
(400 MHz, CDCl3)
d 0.92 (s, 9H, tBu), 1.41 (m, 2H, piperidine), 1.57
(m, 4H, piperidine), 2.35 (m, 2H, 5-H, 6-Hax), 2.50 (m, 4H, piperi-
dine), 2.68 (ddd, 4J 0.6 Hz, 3J 6.2 Hz, 2J 13.6 Hz, 1H, CHaHbNR2), 2.87
(ddd, 4J 1.0 Hz, 3J 6.7 Hz, 2J 13.6 Hz, 1H, CHaHbNR2), 3.26 (dd, 3J
2.3 Hz, 2J 11.3 Hz, 1H, 6-Heq), 3.49 (dd, 3J 10.9 Hz, 2J 11.6 Hz, 1H, 4-
(ATR):
n
(cmꢂ1)¼2958 (w), 2872 (w), 1374 (w), 1080 (s), 1022 (s),
1009 (s), 972 (m), 602 (m), 452 (m); 1H NMR (400 MHz, CDCl3)
d
0.93 (s, 9H, tBu), 1.27 (t, 3J 7.4 Hz, 3H, CH2CH3), 2.35 (m, 1H, 5-H),
H
ax), 4.22 (ddt, 4J 0.9, 1.6 Hz, 3J 6.4 Hz, 1H, 2-H), 4.29 (ddd, 4J 3.0 Hz,
2.46 (dd, 3J 13.0 Hz, 2J 13.0 Hz, 1H, 6-Hax), 2.65 (q, 3J 7.4 Hz, 2H,
3J 3.0 Hz, 2J 11.5 Hz,1H, 4-Heq); 13C NMR (100 MHz, CDCl3)
d 23.9 (d),
CH2CH3), 2.95 (dd, 2J 1.9 Hz, 1H, 3J 6.9 Hz, CH2SEt), 3.32 (m, 1H, 6-
25.6 (d), 27.2 (s), 31.4 (q), 32.5 (t), 46.2 (d), 55.3 (d), 58.3 (d), 71.4 (d),
H
eq), 3.53 (dd, 3J 10.9 Hz, 2J 11.6 Hz, 1H, 4-Hax), 4.13 (t, J 6.9 Hz,
89.0 (t); m/z (FAB) 274 (MHþ); HRMS (FAB): MHþ, found 274.1836.
1H, 2-H), 4.31 (ddd, 4J 2.6 Hz, 3J 3.4 Hz, 2J 11.6 Hz, 1H, 4-Heq); 13C
C14H28NO2S requires 276.1835.
NMR (100 MHz, CDCl3) d 14.7 (s), 27.2 (s), 27.2 (d), 31.3 (q), 31.7 (d),
32.3 (t), 46.4 (d), 71.8 (d), 91.3 (t); m/z (FAB) 251 (MHþ); HRMS
5.18. (2R,3R,5S) and (2S,3R,5S) Dimethyl 2-[(5-tert-butyl-3-
oxido-1,3-oxathian-2-yl)methyl]malonate (31ax and 31eq)
(FAB): MHþ, found 251.1135. C9H17O2S requires 251.1135.
5.16. (2S,3S,5S)-5-tert-Butyl-2-(ethylthiomethyl)-1,3-
oxathiane 3-oxide (32eq) and (2S,3S,5S)-5-tert-butyl-2-(me-
thoxymethyl)-1,3-oxathiane 3-oxide (33eq)
NaH (38.6 mg, 1.61 mmol) was added to a solution of vinyl
sulfoxide 25 (75.6 mg, 0.40 mmol) and dimethyl malonate (185 mL,
1.61 mmol) in THF (6 mL) and the suspension was stirred for 22 d at
50 ꢁC. Saturated aqueous NH4Cl solution (1 mL) was added and
most of the THF was removed in vacuo. The remnant was dissolved
in CH2Cl2/H2O (1:1, 10 mL) and the aqueous layer was extracted
with CH2Cl2 (2ꢀ3 mL). The combined organic layers were dried
NaH (25.8 mg, 1.07 mmol) was added to a solution of vinyl
sulfoxide 23 (101 mg, 0.54 mmol) and ethanethiol (79.3
mL,
1.07 mmol) in MeOH (10 mL). After stirring for 23 d at 50 ꢁC